Viridian Therapeutics (VRDN) Gains Momentum In Pre-Market Trading
Fahim Awan
December 16, 2024
As of the most recent check, shares of Viridian Therapeutics, Inc. (NASDAQ: VRDN) have increased by 24.95% during pre-market activity, to $22.30. Positive clinical trial